Clay Northam Wealth Management’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,627
Closed -$3.14K 94
2024
Q1
$3.14K Hold
16,627
﹤0.01% 89
2023
Q4
$2.7K Hold
16,627
﹤0.01% 80
2023
Q3
$7.35K Buy
16,627
+3,000
+22% +$1.37K 0.01% 78
2023
Q2
$5.03K Hold
13,627
﹤0.01% 78
2023
Q1
$24.8K Hold
13,627
0.03% 80
2022
Q4
$28.2K Hold
13,627
0.03% 77
2022
Q3
$41K Hold
13,627
0.05% 79
2022
Q2
$44K Buy
+13,627
New +$73.8K 0.05% 78

Other funds holding HLTH

Clay Northam Wealth Management's HLTH Position: Q2 2024 in Review

Clay Northam Wealth Management sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 16,627 shares — an estimated $3.14K sold.

Clay Northam Wealth Management first reported a position in HLTH in Q2 2022 and held it in 8 quarters. The position peaked at $44K in Q2 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Clay Northam Wealth Management reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Clay Northam Wealth Management sold 16,627 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $3.14K.
  • Clay Northam Wealth Management first reported a position in Cue Health Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Clay Northam Wealth Management's Cue Health Inc. Common Stock position peaked at $44K in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Clay Northam Wealth Management's 13F filing for Q2 2024, filed 19 Jul 2024.